Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
- 1 July 1992
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 118 (7), 547-550
- https://doi.org/10.1007/bf01225271
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.Journal of Clinical Oncology, 1991
- Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.1989
- Long-term survival in peritoneal mesothelioma the role of radiotherapy and combined modality treatmentCancer, 1987
- Ovarian cancerCurrent Problems in Cancer, 1987
- Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaCancer, 1986
- EARLY PERITONEAL MESOTHELIOMA: A TREATABLE MALIGNANCYThe Lancet, 1985
- Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.1985
- Intracavitary cisplatin chemotherapy for mesothelioma.1985
- Reporting results of cancer treatmentCancer, 1981
- PHARMACOKINETICS OF ADRIAMYCIN AND TISSUE PENETRATION IN MURINE OVARIAN-CANCER1979